Comparison between bupivacaine 0.125% and ropivacaine 0.2% for epidural administration to outpatients with chronic low back pain

European Journal of Anaesthesiology

Volumn 21, Issue 1, 2004, Pages 32-37

  Lierz, Peter ^a   Gustorff, B ^b   Markow, G ^b   Felleiter, P ^c  

^a Marienkrankenhaus Soest ^*  (Germany)

^b UNIVERSITY OF VIENNA   (Austria)

^c SWISS PARAPLEGIC RESEARCH   (Switzerland)

Author keywords

Anaesthesia, Conduction, nerve block; Anaesthesia, epidural; Anaesthetics, Local, bupivacaine, ropivacaine; Back Pain, low back pain; Injections, epidural; Physical Therapy

Indexed keywords

BUPIVACAINE; PLACEBO; ROPIVACAINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; EPIDURAL ANESTHESIA; FEMALE; HEADACHE; HEMODYNAMICS; HUMAN; LOW BACK PAIN; MALE; MOTOR NERVE BLOCK; NERVE BLOCK; OUTPATIENT; PHYSIOTHERAPY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; VISUAL ANALOG SCALE;

ADULT; AGED; AMIDES; ANALGESIA, EPIDURAL; ANESTHETICS, LOCAL; BUPIVACAINE; COMBINED MODALITY THERAPY; DOUBLE-BLIND METHOD; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; LOW BACK PAIN; MALE; MIDDLE AGED; PAIN MEASUREMENT; PHYSICAL THERAPY MODALITIES;

EID: 0347993944     PISSN: 02650215     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0265021504001061     Document Type: Article

References (12)

1. Morrison LM, Emanuelsson BM, McClure JH, et al. Efficacy and kinetics of extradural ropivacaine: comparison with bupivacaine. Br J Anaesth 1994; 72: 164-169.
2. Bromage PR. Epidural Analgesia. Philadelphia, USA: WB Saunders, 1978: 131-148.
3. Fischer C, Blanie P, Jaouen E, Vayssiere C, Kaloul I, Coltat JC. Ropivacaine, 0.1%, plus sufentanil, 0.5 μg/mL, versus: bupivacaine, 0.1%, plus sufentanil, 0.5 μg/mL, using patient-controlled epidural analgesia for labor: a double-blind comparison. Anesthesiology 2000; 92: 1588-1593.
4. White AH, Derby R, Wynne G. Epidural injections for the diagnosis and treatment of low-back pain. Spine 1980; 5: 78-86.
5. Stanton-Hicks M. Low back pain: opportunities and problems of management. Anästhesiol Intensivmed Notfallmed Schmerzther 1998; 33: 806-809.
6. Lierz P. Pain management with spinal and epidural analgesia. Acta Anaesth Scand 1997; 41: 186-188.
7. Polley L, Columb MO, Naughton NN, Wagner D, van den Ven CJM. Relative analgesic potencies of ropivacaine and bupivacaine for epidural analgesia in labor. Anesthesiology 1999; 90: 944-950.
8. Brodner G, Mertes N, Van Aken H, et al. Epidural analgesia with local anesthetics after abdominal surgery: earlier motor recovery with 0.2% ropivacaine than 0.175% bupivacaine. Anesth Analg 1999; 88: 128-133.
9. Brodner G, Mertes N, Van Aken H, et al. What concentration of sufentanil should be combined with ropivacaine 0.2% wt/vol for postoperative patient-controlled epidural analgesia. Anesth Analg 2000; 90: 649-657.
10. Bader AM, Datta S, Flanagan H, Covino BG. Comparison of bupivacaine- and ropivacaine-induced conduction blockade in the isolated rabbit vagus nerve. Anesth Analg 1989; 68:724-727.
11. Reiz S, Häggamark S, Johannsson G, Nath S. Cardio-toxicity of ropivacaine: a new amide local anaesthetic agent. Acta Anaesthesiol Scand 1989; 33: 93-98.
12. Scott DB, Lee A, Fagan D, et al. Acute toxicity of ropivacaine compared with that of bupivacaine. Anesth Analg 1989; 69: 563-569.